ATCC and iPS Academia Japan, Inc. Enter into Patent License Agreement to Distribute iPS Cells and iPS Cell-Derived Cells

Published: Jun 15, 2011

MANASSAS, Va.--(BUSINESS WIRE)--ATCC, the premier biological materials resource and standards organization, and iPS Academia Japan, Inc. (Kyoto, Japan) (AJ) today announced a worldwide non-exclusive licensing agreement for AJ’s induced pluripotent stem (iPS) cell patent portfolio. The portfolio arises from work by Professor Shinya Yamanaka, MD, PhD, Center for iPS Cell Research and Application (CiRA) at the University of Kyoto, Japan.

Back to news